N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes

التفاصيل البيبلوغرافية
العنوان: N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes
المؤلفون: Anders Green, Anne Katrin Sjølie, Mads Nybo, Jakob Grauslund
المصدر: Grauslund, J, Nybo, M, Green, A & Sjølie, A K 2010, ' N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 70, no. 6, pp. 392-8 .
بيانات النشر: Informa UK Limited, 2010.
سنة النشر: 2010
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Clinical Biochemistry, Population, Blood Pressure, Gastroenterology, Nephropathy, Diabetic nephropathy, Internal medicine, Diabetes mellitus, Natriuretic Peptide, Brain, Odds Ratio, medicine, Albuminuria, Humans, Diabetic Nephropathies, cardiovascular diseases, education, Aged, Macrovascular disease, Type 1 diabetes, education.field_of_study, business.industry, General Medicine, Diabetic retinopathy, Middle Aged, Brain natriuretic peptide, medicine.disease, Peptide Fragments, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Endocrinology, Female, business, Diabetic Angiopathies, hormones, hormone substitutes, and hormone antagonists
الوصف: To evaluate N-terminal pro brain natriuretic peptide (NT-proBNP) as a marker of long-term micro- and macrovascular complications in type 1 diabetes.This was a cross-sectional study of 208 long-term surviving type 1 diabetic patients from a population-based cohort from Fyn County, Denmark. In a clinical examination in 2007-2008, NT-proBNP was measured and related to proliferative diabetic retinopathy (PDR), nephropathy, neuropathy and macrovascular disease.Median age and duration of diabetes was 58.7 and 43 years, respectively. Median NT-proBNP concentration was 78 pg/ml (10th-90th percentile 25-653 pg/ml). The NT-proBNP level (89 vs. 71 pg/ml, p = 0.02) was higher in women. In univariate analyses, NT-proBNP was associated with age, duration of diabetes, diastolic blood pressure (inversely), nephropathy, neuropathy and macrovascular disease. For instance, median NT-proBNP concentrations were 70, 91 and 486 pg/ml for patients with normo-, micro- and macroalbuminuria, respectively (p0.01). When adjusted for age, sex, duration of diabetes, high sensitivity CRP, HbA(1c), diastolic blood pressure and smoking, higher NT-proBNP concentrations (4th vs. 1st quartile) were related to nephropathy (odds ratio [OR] 5.03; 95% confidence interval [CI] 1.77-14.25), neuropathy (OR 4.08; 95% CI 1.52-10.97) and macrovascular disease (OR 5.84; 95% CI 1.65-20.74). There was no association with PDR.NT-proBNP has traditionally been described as a marker of heart failure and left ventricular dysfunction. In this study of long-term surviving type 1 diabetic patients, we found NT-proBNP associated with nephropathy, neuropathy and macrovascular disease. If confirmed by prospective studies, NT-proBNP might be a useful prognostic marker of diabetes-related complications.
تدمد: 1502-7686
0036-5513
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c746d42c0a9c7160ea1d6997f3f523cTest
https://doi.org/10.3109/00365513.2010.497869Test
حقوق: RESTRICTED
رقم الانضمام: edsair.doi.dedup.....6c746d42c0a9c7160ea1d6997f3f523c
قاعدة البيانات: OpenAIRE
ResultId 1
Header edsair
OpenAIRE
edsair.doi.dedup.....6c746d42c0a9c7160ea1d6997f3f523c
793
3

unknown
793.393859863281
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6c746d42c0a9c7160ea1d6997f3f523c&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Anders+Green%22">Anders Green</searchLink><br /><searchLink fieldCode="AR" term="%22Anne+Katrin+Sjølie%22">Anne Katrin Sjølie</searchLink><br /><searchLink fieldCode="AR" term="%22Mads+Nybo%22">Mads Nybo</searchLink><br /><searchLink fieldCode="AR" term="%22Jakob+Grauslund%22">Jakob Grauslund</searchLink> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Grauslund, J, Nybo, M, Green, A & Sjølie, A K 2010, ' N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 70, no. 6, pp. 392-8 . )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Informa UK Limited, 2010. )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2010 )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+Biochemistry%22">Clinical Biochemistry</searchLink><br /><searchLink fieldCode="DE" term="%22Population%22">Population</searchLink><br /><searchLink fieldCode="DE" term="%22Blood+Pressure%22">Blood Pressure</searchLink><br /><searchLink fieldCode="DE" term="%22Gastroenterology%22">Gastroenterology</searchLink><br /><searchLink fieldCode="DE" term="%22Nephropathy%22">Nephropathy</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetic+nephropathy%22">Diabetic nephropathy</searchLink><br /><searchLink fieldCode="DE" term="%22Internal+medicine%22">Internal medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetes+mellitus%22">Diabetes mellitus</searchLink><br /><searchLink fieldCode="DE" term="%22Natriuretic+Peptide%2C+Brain%22">Natriuretic Peptide, Brain</searchLink><br /><searchLink fieldCode="DE" term="%22Odds+Ratio%22">Odds Ratio</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Albuminuria%22">Albuminuria</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetic+Nephropathies%22">Diabetic Nephropathies</searchLink><br /><searchLink fieldCode="DE" term="%22cardiovascular+diseases%22">cardiovascular diseases</searchLink><br /><searchLink fieldCode="DE" term="%22education%22">education</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Macrovascular+disease%22">Macrovascular disease</searchLink><br /><searchLink fieldCode="DE" term="%22Type+1+diabetes%22">Type 1 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22education%2Efield%5Fof%5Fstudy%22">education.field_of_study</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22General+Medicine%22">General Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetic+retinopathy%22">Diabetic retinopathy</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Brain+natriuretic+peptide%22">Brain natriuretic peptide</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%22">medicine.disease</searchLink><br /><searchLink fieldCode="DE" term="%22Peptide+Fragments%22">Peptide Fragments</searchLink><br /><searchLink fieldCode="DE" term="%22Cross-Sectional+Studies%22">Cross-Sectional Studies</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetes+Mellitus%2C+Type+1%22">Diabetes Mellitus, Type 1</searchLink><br /><searchLink fieldCode="DE" term="%22Endocrinology%22">Endocrinology</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetic+Angiopathies%22">Diabetic Angiopathies</searchLink><br /><searchLink fieldCode="DE" term="%22hormones%2C+hormone+substitutes%2C+and+hormone+antagonists%22">hormones, hormone substitutes, and hormone antagonists</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => To evaluate N-terminal pro brain natriuretic peptide (NT-proBNP) as a marker of long-term micro- and macrovascular complications in type 1 diabetes.This was a cross-sectional study of 208 long-term surviving type 1 diabetic patients from a population-based cohort from Fyn County, Denmark. In a clinical examination in 2007-2008, NT-proBNP was measured and related to proliferative diabetic retinopathy (PDR), nephropathy, neuropathy and macrovascular disease.Median age and duration of diabetes was 58.7 and 43 years, respectively. Median NT-proBNP concentration was 78 pg/ml (10th-90th percentile 25-653 pg/ml). The NT-proBNP level (89 vs. 71 pg/ml, p = 0.02) was higher in women. In univariate analyses, NT-proBNP was associated with age, duration of diabetes, diastolic blood pressure (inversely), nephropathy, neuropathy and macrovascular disease. For instance, median NT-proBNP concentrations were 70, 91 and 486 pg/ml for patients with normo-, micro- and macroalbuminuria, respectively (p0.01). When adjusted for age, sex, duration of diabetes, high sensitivity CRP, HbA(1c), diastolic blood pressure and smoking, higher NT-proBNP concentrations (4th vs. 1st quartile) were related to nephropathy (odds ratio [OR] 5.03; 95% confidence interval [CI] 1.77-14.25), neuropathy (OR 4.08; 95% CI 1.52-10.97) and macrovascular disease (OR 5.84; 95% CI 1.65-20.74). There was no association with PDR.NT-proBNP has traditionally been described as a marker of heart failure and left ventricular dysfunction. In this study of long-term surviving type 1 diabetic patients, we found NT-proBNP associated with nephropathy, neuropathy and macrovascular disease. If confirmed by prospective studies, NT-proBNP might be a useful prognostic marker of diabetes-related complications. )
Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1502-7686<br />0036-5513 )
Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c746d42c0a9c7160ea1d6997f3f523c" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c746d42c0a9c7160ea1d6997f3f523c</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.3109/00365513.2010.497869" linkWindow="_blank">https://doi.org/10.3109/00365513.2010.497869</link> )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => RESTRICTED )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....6c746d42c0a9c7160ea1d6997f3f523c )
RecordInfo Array ( [BibEntity] => Array ( [Languages] => Array ( [0] => Array ( [Text] => Undetermined ) ) [PhysicalDescription] => Array ( [Pagination] => Array ( [PageCount] => 7 [StartPage] => 392 ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Adult [Type] => general ) [1] => Array ( [SubjectFull] => Male [Type] => general ) [2] => Array ( [SubjectFull] => medicine.medical_specialty [Type] => general ) [3] => Array ( [SubjectFull] => Clinical Biochemistry [Type] => general ) [4] => Array ( [SubjectFull] => Population [Type] => general ) [5] => Array ( [SubjectFull] => Blood Pressure [Type] => general ) [6] => Array ( [SubjectFull] => Gastroenterology [Type] => general ) [7] => Array ( [SubjectFull] => Nephropathy [Type] => general ) [8] => Array ( [SubjectFull] => Diabetic nephropathy [Type] => general ) [9] => Array ( [SubjectFull] => Internal medicine [Type] => general ) [10] => Array ( [SubjectFull] => Diabetes mellitus [Type] => general ) [11] => Array ( [SubjectFull] => Natriuretic Peptide, Brain [Type] => general ) [12] => Array ( [SubjectFull] => Odds Ratio [Type] => general ) [13] => Array ( [SubjectFull] => medicine [Type] => general ) [14] => Array ( [SubjectFull] => Albuminuria [Type] => general ) [15] => Array ( [SubjectFull] => Humans [Type] => general ) [16] => Array ( [SubjectFull] => Diabetic Nephropathies [Type] => general ) [17] => Array ( [SubjectFull] => cardiovascular diseases [Type] => general ) [18] => Array ( [SubjectFull] => education [Type] => general ) [19] => Array ( [SubjectFull] => Aged [Type] => general ) [20] => Array ( [SubjectFull] => Macrovascular disease [Type] => general ) [21] => Array ( [SubjectFull] => Type 1 diabetes [Type] => general ) [22] => Array ( [SubjectFull] => education.field_of_study [Type] => general ) [23] => Array ( [SubjectFull] => business.industry [Type] => general ) [24] => Array ( [SubjectFull] => General Medicine [Type] => general ) [25] => Array ( [SubjectFull] => Diabetic retinopathy [Type] => general ) [26] => Array ( [SubjectFull] => Middle Aged [Type] => general ) [27] => Array ( [SubjectFull] => Brain natriuretic peptide [Type] => general ) [28] => Array ( [SubjectFull] => medicine.disease [Type] => general ) [29] => Array ( [SubjectFull] => Peptide Fragments [Type] => general ) [30] => Array ( [SubjectFull] => Cross-Sectional Studies [Type] => general ) [31] => Array ( [SubjectFull] => Diabetes Mellitus, Type 1 [Type] => general ) [32] => Array ( [SubjectFull] => Endocrinology [Type] => general ) [33] => Array ( [SubjectFull] => Female [Type] => general ) [34] => Array ( [SubjectFull] => business [Type] => general ) [35] => Array ( [SubjectFull] => Diabetic Angiopathies [Type] => general ) [36] => Array ( [SubjectFull] => hormones, hormone substitutes, and hormone antagonists [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Anders Green ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Anne Katrin Sjølie ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Mads Nybo ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Jakob Grauslund ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 24 [M] => 06 [Type] => published [Y] => 2010 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 15027686 ) [1] => Array ( [Type] => issn-print [Value] => 00365513 ) [2] => Array ( [Type] => issn-locals [Value] => edsair ) ) [Numbering] => Array ( [0] => Array ( [Type] => volume [Value] => 70 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Scandinavian Journal of Clinical and Laboratory Investigation [Type] => main ) ) ) ) ) ) )
IllustrationInfo